Monica Healthcare raises $3M for second gen wireless fetal monitor
Summary
UK-based fetal monitor maker Monica Healthcare raised $3 million (2 million British pounds) from existing investors Catapult Ventures, the New Hill Growth Fund, East Midlands Business Angels, the University of Nottingham as well as new investors Wren Capital, Origin Capital, Catamaran Ventures, and the London Business Angels. The product is sold in the USA, Europe, Brazil, Russia, India, and China and is used to monitor the delivery of over 100,000 babies every year, according to the company. Monica said that clinical trials at the Albert Einstein College of Medicine in 2011 demonstrated that AN24 also performs well for obese pregnant women. The offering can connect to another Monica service, called VS program, which runs on a Bluetooth-enabled PC, notebook or tablet. From the VS program users can view and store the FHR, MHR, UA, maternal activity, and other events that AN24 monitors.